Michael Serbin, PharmD

Background: The impact of possible tardive dyskinesia (TD) was assessed in RE KINECT, a real-world study of antipsychotic-treated outpatients. Based on clinician assessments, patients wer...

William Lenderking , PhD;

Michael Serbin , PharmD;

Chuck Younan , PharmD;

Ericha Franey , PhD;

Andrew J. Cutler , MD;

Stanley Caroff , MD;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Michael Serbin, PharmD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products